Prostate Cancer - Results from #220

A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men. March 30, 2022

Cumulative Burden of Psychiatric Disorders and Self-Harm Across 26 Adult Cancers March 29, 2022

Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development March 29, 2022

Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression. March 29, 2022

Comparative Effectiveness of Abiraterone and Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer in Taiwan. March 29, 2022

Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology. March 29, 2022

Retrospective analysis of MV-kV imaging-based fiducial tracking in prostate SBRT treatment. March 29, 2022

Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial. March 29, 2022

Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study. March 28, 2022

Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer. March 28, 2022

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer. March 28, 2022

Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States. March 28, 2022

Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer. March 28, 2022

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy. March 25, 2022

Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP). March 25, 2022

Effect of Prostate MRI Interpretation Experience on PPV Using PI-RADS Version 2: A 6-Year Assessment Among Eight Fellowship-Trained Radiologists. March 25, 2022

Pre-activation of autophagy impacts response to olaparib in prostate cancer cells. March 25, 2022

Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. March 25, 2022

FDA Approves Pluvicto for Metastatic Castration-Resistant Prostate Cancer March 24, 2022

The impact of a fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer: a pilot implementation study. March 24, 2022

Page 12 of 1224

email news signup